Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerShikhar Sharma, Meghan Hattarki, Joan Cao et al.|Cell chemical biology|2023Cited by 72
Abstract C029: PF-07248144 – First-in-class potent, selective KAT6i in ER+HER2− breast cancerShikhar Sharma, Thomas A. Paul, Paul Richardson et al.|Molecular Cancer Therapeutics|2025Cited by 0